Nothing Special   »   [go: up one dir, main page]

PL374558A1 - Sposoby oczyszczania lewofloksacyny - Google Patents

Sposoby oczyszczania lewofloksacyny

Info

Publication number
PL374558A1
PL374558A1 PL02374558A PL37455802A PL374558A1 PL 374558 A1 PL374558 A1 PL 374558A1 PL 02374558 A PL02374558 A PL 02374558A PL 37455802 A PL37455802 A PL 37455802A PL 374558 A1 PL374558 A1 PL 374558A1
Authority
PL
Poland
Prior art keywords
levofloxacin
purification
methods
Prior art date
Application number
PL02374558A
Other languages
English (en)
Inventor
Valerie Niddam-Hildesheim
Neomi Gershon
Eduard Schwartz
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/263,192 external-priority patent/US7629458B2/en
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL374558A1 publication Critical patent/PL374558A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)
PL02374558A 2001-11-29 2002-11-27 Sposoby oczyszczania lewofloksacyny PL374558A1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33431601P 2001-11-29 2001-11-29
US35493902P 2002-02-11 2002-02-11
US26296502A 2002-10-03 2002-10-03
US10/263,192 US7629458B2 (en) 2001-10-03 2002-10-03 Preparation of levofloxacin and hemihydrate thereof

Publications (1)

Publication Number Publication Date
PL374558A1 true PL374558A1 (pl) 2005-10-31

Family

ID=31892240

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02374558A PL374558A1 (pl) 2001-11-29 2002-11-27 Sposoby oczyszczania lewofloksacyny

Country Status (13)

Country Link
EP (1) EP1460997A4 (pl)
JP (3) JP2005527484A (pl)
CN (1) CN1596256A (pl)
AU (1) AU2002365416A1 (pl)
CA (1) CA2466860A1 (pl)
HR (1) HRP20040546A2 (pl)
HU (1) HUP0500285A3 (pl)
IL (1) IL162172A0 (pl)
IS (1) IS7288A (pl)
MX (1) MXPA04005196A (pl)
NO (1) NO20042731L (pl)
PL (1) PL374558A1 (pl)
WO (1) WO2003045329A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1451194B2 (en) 2001-10-03 2009-12-16 Teva Pharmaceutical Industries Ltd. Preparation of levofloxacin hemihydrate
US20060276463A1 (en) * 2002-12-16 2006-12-07 Sharma Tarun K Pure levofloxacin hemihydrate and processes for preparation thereof
KR100704641B1 (ko) * 2004-07-21 2007-04-06 주식회사유한양행 고순도의 레보플록사신 제조방법
JP2006273718A (ja) * 2005-03-28 2006-10-12 Shiono Chemical Co Ltd レボフロキサシン・１／２水和物の製法
CN1321121C (zh) * 2005-04-21 2007-06-13 浙江医药股份有限公司新昌制药厂 左氧氟沙星制备及后处理方法
US7964723B2 (en) 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CN102070650B (zh) * 2011-01-28 2012-06-27 山东省药品检验所 左氧氟沙星-n-氧化物的制备方法
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
CN105823851A (zh) * 2015-12-15 2016-08-03 浙江海洋学院 一种检测海水中氧氟沙星对映体的方法
CN108218892A (zh) * 2018-03-16 2018-06-29 乐山职业技术学院 一种左氧氟沙星的纯化方法
CN114507242B (zh) * 2022-01-26 2023-05-19 上虞京新药业有限公司 高光学纯度左氧氟沙星的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO166131C (no) * 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
US5237060A (en) * 1985-12-10 1993-08-17 Bayer Aktiengesellschaft Process of preparing enantiomerically pure 1,8-bridged 4-quinolone-3-carboxylic acids
TW208013B (pl) * 1990-03-01 1993-06-21 Daiichi Co Ltd
US5521310A (en) * 1992-10-07 1996-05-28 Derivados Del Etilo, S.A. Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
KR0125115B1 (ko) * 1994-03-22 1997-12-05 김은영 (-)피페라진 벤즈옥사진 유도체의 제조방법
KR100309871B1 (ko) * 1999-02-24 2001-10-29 윤종용 (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법
EP1451194B2 (en) * 2001-10-03 2009-12-16 Teva Pharmaceutical Industries Ltd. Preparation of levofloxacin hemihydrate

Also Published As

Publication number Publication date
CA2466860A1 (en) 2003-06-05
CN1596256A (zh) 2005-03-16
AU2002365416A1 (en) 2003-06-10
JP2005527484A (ja) 2005-09-15
HRP20040546A2 (en) 2004-10-31
HUP0500285A3 (en) 2009-03-30
WO2003045329A2 (en) 2003-06-05
NO20042731L (no) 2004-06-29
EP1460997A4 (en) 2005-06-15
WO2003045329A3 (en) 2004-02-19
MXPA04005196A (es) 2005-11-23
JP2008007517A (ja) 2008-01-17
HUP0500285A2 (hu) 2005-06-28
IL162172A0 (en) 2005-11-20
IS7288A (is) 2004-06-21
JP2006219496A (ja) 2006-08-24
EP1460997A2 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
HK1126953A1 (en) Fixtures for holding micro-organs
AU2002348135A1 (en) Methods for the treatment of addiction
HK1056864A1 (en) Syngas purification process
GB0128457D0 (en) Knowledge system
AU2002301971A1 (en) Syngas Purification Process
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
SI1697383T1 (sl) Postopek za čiščenje takrolimusa
HUP0500285A3 (en) Methods for the purification of levofloxacin
HUP0302530A3 (en) Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid
GB0209222D0 (en) Purification process
GB0123145D0 (en) Apparatus for the purification of water
PL373627A1 (pl) Sposób wytwarzania melaminy
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
PL371583A1 (pl) Sposób wytwarzania 7 alfa-metylosteroidów
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
GB0113300D0 (en) Purification process
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2002366004A1 (en) Process for the purification of contaminated oils
GB0116022D0 (en) Purification process
IL159508A0 (en) Apparatus for the purification of water
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
SI1395580T1 (en) Method for the purification of triazolylmethylepoxides
AU2003248597A1 (en) The purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
AU2002316900A1 (en) Method for the purification of triazolylmethylepoxides

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)